ArticleBlood2009

Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.

Agnes S M Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.